|
DE3867635D1
(de)
*
|
1987-03-13 |
1992-02-20 |
Micro Vesicular Systems |
Lipidversikel aus grenzflaechenaktiven stoffen und sterolen.
|
|
US5023086A
(en)
*
|
1987-03-13 |
1991-06-11 |
Micro-Pak, Inc. |
Encapsulated ionophore growth factors
|
|
US5234767A
(en)
*
|
1987-03-13 |
1993-08-10 |
Micro-Pak, Inc. |
Hybrid paucilamellar lipid vesicles
|
|
US5219538A
(en)
*
|
1987-03-13 |
1993-06-15 |
Micro-Pak, Inc. |
Gas and oxygen carrying lipid vesicles
|
|
US5628936A
(en)
*
|
1987-03-13 |
1997-05-13 |
Micro-Pak, Inc. |
Hybrid paucilamellar lipid vesicles
|
|
US5474848A
(en)
*
|
1987-03-13 |
1995-12-12 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
|
US5147723A
(en)
*
|
1987-07-28 |
1992-09-15 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
|
US5811119A
(en)
*
|
1987-05-19 |
1998-09-22 |
Board Of Regents, The University Of Texas |
Formulation and use of carotenoids in treatment of cancer
|
|
EP0324455A3
(de)
*
|
1988-01-15 |
1991-03-27 |
Hans O. Ribi |
Neue polymerische Immuno-Adjuvans
|
|
US5019392A
(en)
*
|
1988-03-03 |
1991-05-28 |
Micro-Pak, Inc. |
Encapsulation of parasiticides
|
|
US5160669A
(en)
*
|
1988-03-03 |
1992-11-03 |
Micro Vesicular Systems, Inc. |
Method of making oil filled paucilamellar lipid vesicles
|
|
US5013497A
(en)
*
|
1988-03-03 |
1991-05-07 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
|
US5104736A
(en)
*
|
1988-03-03 |
1992-04-14 |
Micro-Pak, Inc. |
Reinforced paucilamellar lipid vesicles
|
|
US4895452A
(en)
*
|
1988-03-03 |
1990-01-23 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
|
US5019174A
(en)
*
|
1988-03-03 |
1991-05-28 |
Micro Vesicular Systems, Inc. |
Removing oil from surfaces with liposomal cleaner
|
|
US5032457A
(en)
*
|
1988-03-03 |
1991-07-16 |
Micro Vesicular Systems, Inc. |
Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants
|
|
US4906476A
(en)
*
|
1988-12-14 |
1990-03-06 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs in lungs
|
|
US5510117A
(en)
*
|
1989-03-09 |
1996-04-23 |
Micro-Pak, Inc. |
Entrapment vehicle and method
|
|
GB8906234D0
(en)
*
|
1989-03-17 |
1989-05-04 |
Albright & Wilson |
Agrochemical suspensions
|
|
WO1991004013A1
(en)
*
|
1989-09-21 |
1991-04-04 |
Micro Vesicular Systems, Inc. |
Hybrid paucilamellar lipid vesicles
|
|
US5227165A
(en)
*
|
1989-11-13 |
1993-07-13 |
Nova Pharmaceutical Corporation |
Liposphere delivery systems for local anesthetics
|
|
US5188837A
(en)
*
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
|
IE904098A1
(en)
*
|
1989-11-13 |
1991-05-22 |
Nova Pharm Corp |
Lipospheres for controlled delivery of substances
|
|
FR2657607B1
(fr)
*
|
1990-01-30 |
1992-04-30 |
Durand Muriel |
Procede de protection de la dihydroxyacetone, dihydroxyacetone protegee par ce procede et produit cosmetique contenant une telle dihydroxyacetone protegee.
|
|
US5213810A
(en)
*
|
1990-03-30 |
1993-05-25 |
American Cyanamid Company |
Stable compositions for parenteral administration and method of making same
|
|
US5165994A
(en)
*
|
1990-06-05 |
1992-11-24 |
University Of Delaware |
Spontaneous equilbrium surfactant vesicles
|
|
CA2046830C
(en)
|
1990-07-19 |
1999-12-14 |
Patrick P. Deluca |
Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
|
|
US6165500A
(en)
*
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
|
WO1992003123A1
(en)
*
|
1990-08-28 |
1992-03-05 |
Liposome Technology, Inc. |
Liposome alternative bilayer formulations
|
|
ES2089226T3
(es)
*
|
1990-09-06 |
1996-10-01 |
Johnson & Son Inc S C |
Procedimiento para estabilizar liposomas y composiciones que los contienen.
|
|
US5145604A
(en)
*
|
1990-09-19 |
1992-09-08 |
S. C. Johnson & Son, Inc. |
Aqueous emulsion and aerosol delivery system using same
|
|
US5091111A
(en)
*
|
1990-09-19 |
1992-02-25 |
S. C. Johnson & Son, Inc. |
Aqueous emulsion and aersol delivery system using same
|
|
US5256422A
(en)
*
|
1991-03-28 |
1993-10-26 |
Micro Vesicular Systems, Inc. |
Lipid vesicle containing water-in-oil emulsions
|
|
BR9205819A
(pt)
*
|
1991-03-28 |
1994-06-07 |
Micro Vesicular Systems |
Emulsoes de água em óleo contendo vesículas de lipídio
|
|
DE4121945C2
(de)
*
|
1991-07-03 |
1993-11-04 |
Merz & Co Gmbh & Co |
Verfahren zur herstellung von stabilen, hydrophilen oder ambiphilen creme-zubereitungen, enthaltend vesikulaere bestandteile, stabile creme-zubereitungen mit vesikulaeren bestandteilen und deren verwendung
|
|
US5213805A
(en)
*
|
1991-07-25 |
1993-05-25 |
Micro Vesicular Systems, Inc. |
Lipid vesicles having n,n-dimethylamide derivatives as their primary lipid
|
|
US5260065A
(en)
*
|
1991-09-17 |
1993-11-09 |
Micro Vesicular Systems, Inc. |
Blended lipid vesicles
|
|
US5439967A
(en)
*
|
1991-09-17 |
1995-08-08 |
Micro Vesicular Systems, Inc. |
Propylene glycol stearate vesicles
|
|
US5643600A
(en)
*
|
1991-09-17 |
1997-07-01 |
Micro-Pak, Inc. |
Lipid vesicles containing avocado oil unsaponifiables
|
|
US5405615A
(en)
*
|
1991-09-17 |
1995-04-11 |
Micro Vesicular Systems, Inc. |
Sucrose distearate lipid vesicles
|
|
CA2150463A1
(en)
*
|
1992-12-02 |
1994-06-09 |
Donald F. H. Wallach |
Extended duration antacid product
|
|
US5393527A
(en)
*
|
1993-01-04 |
1995-02-28 |
Becton, Dickinson And Company |
Stabilized microspheres and methods of preparation
|
|
CA2153780C
(en)
*
|
1993-01-15 |
2004-04-13 |
Micro Vesicular Systems, Inc. |
Method of inhibiting viral reproduction
|
|
US5853755A
(en)
*
|
1993-07-28 |
1998-12-29 |
Pharmaderm Laboratories Ltd. |
Biphasic multilamellar lipid vesicles
|
|
AU680996B2
(en)
|
1993-12-17 |
1997-08-14 |
Novavax, Inc. |
Method of transmitting a biologically active material to a cell
|
|
JP3836874B2
(ja)
*
|
1994-02-24 |
2006-10-25 |
ノババックス インコーポレイテッド |
免疫アジュバントとして少ラメラ脂質小胞を含むワクチン
|
|
US20020048596A1
(en)
*
|
1994-12-30 |
2002-04-25 |
Gregor Cevc |
Preparation for the transport of an active substance across barriers
|
|
US5629021A
(en)
*
|
1995-01-31 |
1997-05-13 |
Novavax, Inc. |
Micellar nanoparticles
|
|
FR2730928B1
(fr)
*
|
1995-02-23 |
1997-04-04 |
Oreal |
Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique
|
|
US5599548A
(en)
*
|
1995-05-08 |
1997-02-04 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Skin care compositions containing fatty acid amides and retinol or retinyl ester
|
|
US5954998A
(en)
*
|
1995-05-25 |
1999-09-21 |
The Clorox Company |
Liquid peracid precursor colloidal dispersions: oil-core vesicles
|
|
US5902604A
(en)
*
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
|
US5834014A
(en)
*
|
1995-10-06 |
1998-11-10 |
The Regents Of The University Of Michigan |
Stimulation of hair follicles
|
|
US6183774B1
(en)
|
1996-01-31 |
2001-02-06 |
Collaborative Laboratories, Inc. |
Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
|
|
US6071535A
(en)
*
|
1996-01-31 |
2000-06-06 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
|
US5874105A
(en)
*
|
1996-01-31 |
1999-02-23 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
|
US5662957A
(en)
*
|
1996-05-03 |
1997-09-02 |
Novavax, Inc. |
Oil containing lipid vesicles with marine applications
|
|
US5700679A
(en)
*
|
1996-06-07 |
1997-12-23 |
Novavax, Inc. |
Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
|
|
US5846551A
(en)
*
|
1996-06-10 |
1998-12-08 |
E-L Management Corp. |
Water-based makeup compositions and methods for their preparation
|
|
US5747051A
(en)
*
|
1996-09-27 |
1998-05-05 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Skin care compositions containing an amide of a hydroxy fatty acid and a retinoid
|
|
US5955092A
(en)
*
|
1996-09-27 |
1999-09-21 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester
|
|
US5935572A
(en)
*
|
1997-01-10 |
1999-08-10 |
Collaborative Laboratories, Inc. |
Composition containing protease separate from glycosidase for removing nits in treating lice infestation
|
|
US6039960A
(en)
*
|
1997-05-28 |
2000-03-21 |
E-L Management Corp. |
Water containing wax-based product
|
|
IS4518A
(is)
|
1997-07-09 |
1999-01-10 |
Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group |
Nýtt lyfjaform fyrir bóluefni
|
|
US5993852A
(en)
*
|
1997-08-29 |
1999-11-30 |
Pharmaderm Laboratories Ltd. |
Biphasic lipid vesicle composition for transdermal administration of an immunogen
|
|
TW476788B
(en)
|
1998-04-08 |
2002-02-21 |
Kimberly Clark Co |
A cleanser and the making process thereof
|
|
GB9824024D0
(en)
*
|
1998-11-03 |
1998-12-30 |
Unilever Plc |
Shampoo compositions
|
|
CZ20012038A3
(cs)
*
|
1998-12-23 |
2001-09-12 |
Idea Ag |
Zdokonalený přípravek pro topické, neinvazivní použití in vivo
|
|
EP1031346B1
(de)
|
1999-01-27 |
2002-05-02 |
Idea Ag |
Nichtinvasive Impfung durch die Haut
|
|
EP1031347B1
(de)
|
1999-01-27 |
2002-04-17 |
Idea Ag |
Transnasaler Transport bzw. Impfung mit hochadaptierbaren Trägern
|
|
US6080211A
(en)
*
|
1999-02-19 |
2000-06-27 |
Igen, Inc. |
Lipid vesicle-based fuel additives and liquid energy sources containing same
|
|
CA2309373A1
(en)
*
|
1999-05-27 |
2000-11-27 |
Johnson & Johnson Consumer Companies, Inc. |
Novel topical formulations
|
|
WO2001001962A1
(en)
*
|
1999-07-05 |
2001-01-11 |
Idea Ag. |
A method for the improvement of transport across adaptable semi-permeable barriers
|
|
US6309664B1
(en)
|
1999-09-15 |
2001-10-30 |
Igen, Incorporated |
Methods, uses and compositions of fluid petrolatum
|
|
US6534078B1
(en)
*
|
1999-10-18 |
2003-03-18 |
Natural Pest Fx, Inc. |
Micro-encapsulated pepper-mustard composition and methods of using the same
|
|
US6375968B1
(en)
|
1999-10-22 |
2002-04-23 |
3M Innovative Properties Company |
Encapsulated active material immobilized in hydrogel microbeads
|
|
US6376514B1
(en)
|
2000-10-17 |
2002-04-23 |
The Procter & Gamble Co. |
Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
|
|
US6540991B2
(en)
|
2001-04-06 |
2003-04-01 |
3M Innovative Properties Company |
Stabilized active materials
|
|
US6562361B2
(en)
|
2001-05-02 |
2003-05-13 |
3M Innovative Properties Company |
Pheromone immobilized in stable hydrogel microbeads
|
|
AU2002353774A1
(en)
*
|
2001-08-01 |
2003-03-24 |
The Procter And Gamble Company |
Products and methods for treating microbial infections
|
|
CA2457595A1
(en)
*
|
2001-08-16 |
2003-02-27 |
Lyfjathroun H.F., Biopharmaceuticals |
A method of producing antibodies ex-vivo
|
|
US6709663B2
(en)
|
2001-08-31 |
2004-03-23 |
Healthpoint, Ltd. |
Multivesicular emulsion drug delivery systems
|
|
EP1304103B1
(de)
*
|
2001-10-22 |
2008-12-31 |
Viroblock SA |
Non-phospholipid Vesikel (npLV) und ihre Verwendung in kosmetischen, therapeutischen und prophylaktischen Anwendungen
|
|
US20030129213A1
(en)
*
|
2001-12-26 |
2003-07-10 |
Gonzalez Anthony D. |
Meta-stable insect repellent emulsion composition and method of use
|
|
US20030219465A1
(en)
*
|
2002-05-23 |
2003-11-27 |
Suresh Kumar Gidwani |
Composition for delivery of dithranol
|
|
US20030232091A1
(en)
*
|
2002-06-17 |
2003-12-18 |
Adi Shefer |
Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
|
|
US7473432B2
(en)
*
|
2002-10-11 |
2009-01-06 |
Idea Ag |
NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
|
|
US20040087564A1
(en)
*
|
2002-10-31 |
2004-05-06 |
Wright D. Craig |
Delivery composition and method
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
NZ546521A
(en)
|
2003-09-29 |
2009-09-25 |
Topigen Pharma Inc |
Oligonucleotide compositions and methods for treating disease including inflammatory conditions
|
|
EP1754532B1
(de)
|
2004-04-05 |
2018-06-20 |
Kanagawa University |
Emulgierend wirkende dispergiermittel, verfahren zum emulgieren und dispergieren damit, emulsionen und emulsionsbrennstoffe
|
|
EA200601648A1
(ru)
|
2004-04-07 |
2007-04-27 |
Зе Юниверсити Оф Джорджия Рисерч Фаундейшн, Инк. |
Глюкозамин и общие пролекарства глюкозамин/противовоспалительный агент, композиции и способы
|
|
US8034796B2
(en)
*
|
2004-04-07 |
2011-10-11 |
The University Of Georgia Research Foundation, Inc. |
Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
|
|
JP4616602B2
(ja)
*
|
2004-09-16 |
2011-01-19 |
大日本塗料株式会社 |
単分散粒子の製造方法
|
|
MX2007005083A
(es)
*
|
2004-10-29 |
2007-10-03 |
Topigen Pharmaceuticals Inc |
Oligonucleotidos antisentido para tratar alergias y proliferacion celular neoplastica.
|
|
CA2584475A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Idea Ag |
Extended surface aggregates in the treatment of skin conditions
|
|
US20120269886A1
(en)
|
2004-12-22 |
2012-10-25 |
Nitto Denko Corporation |
Therapeutic agent for pulmonary fibrosis
|
|
SI2727583T1
(sl)
*
|
2004-12-22 |
2022-01-31 |
Nitto Denko Corporation |
Nosilec učinkovine in komplet nosilca učinkovine za zaviranje fibroze
|
|
JP4533420B2
(ja)
*
|
2004-12-22 |
2010-09-01 |
日東電工株式会社 |
線維化抑制のための薬物担体および薬物担体キット
|
|
WO2006071659A1
(en)
*
|
2004-12-29 |
2006-07-06 |
Trustees Of Boston University |
Delivery of h2 antagonists
|
|
EP1852177B1
(de)
*
|
2005-01-28 |
2014-02-26 |
Japan Science and Technology Agency |
Molekulares aggregat, das dazu befähigt ist, eine phasenumwandlung durch dehydratisierende kondensation zu durchlaufen, und verfahren zur phasenumwandlung davon
|
|
ES2580108T3
(es)
|
2005-07-11 |
2016-08-19 |
Aerie Pharmaceuticals, Inc |
Compuestos de isoquinolina
|
|
ES2747978T3
(es)
*
|
2005-10-03 |
2020-03-12 |
Mark A Pinsky |
Liposomas no fosfolipídicos que comprenden ácido hialurónico
|
|
PT1937301E
(pt)
|
2005-10-18 |
2015-09-14 |
Novavax Inc |
Partículas idênticas a vírus (vlps) da gripe funcionais
|
|
US9572886B2
(en)
|
2005-12-22 |
2017-02-21 |
Nitto Denko Corporation |
Agent for treating myelofibrosis
|
|
CA2652539A1
(en)
*
|
2006-05-19 |
2007-11-29 |
Topigen Pharmaceuticals Inc. |
Oligonucleotides affecting expression of phosphodiesterases
|
|
EP2023896B8
(de)
*
|
2006-05-19 |
2016-09-14 |
Viroblock SA |
Zusammensetzung zur inaktivierung eines virus mit hülle
|
|
EP2526948A1
(de)
|
2006-09-20 |
2012-11-28 |
Aerie Pharmaceuticals, Inc. |
RHO-Kinase-Hemmer
|
|
WO2008083275A2
(en)
*
|
2006-12-28 |
2008-07-10 |
3M Innovative Properties Company |
Dental filler and methods
|
|
US8455513B2
(en)
*
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
|
AU2008206087A1
(en)
*
|
2007-01-18 |
2008-07-24 |
Mark A. Pinsky |
Materials and methods for delivering antioxidants into the skin
|
|
TWI407971B
(zh)
|
2007-03-30 |
2013-09-11 |
日東電工股份有限公司 |
Cancer cells and tumor-related fibroblasts
|
|
EP3127549B1
(de)
|
2007-06-22 |
2019-12-18 |
Children's Medical Center Corporation |
Verfahren und verwendung von einem fragment von saposin a
|
|
FR2917976B1
(fr)
*
|
2007-06-29 |
2010-05-28 |
Galderma Sa |
Composition dermatologique comprenant des vehicules lipidiques de calcitriol, son procede de preparation et son utilisation
|
|
PT2540312E
(pt)
|
2007-07-19 |
2015-08-31 |
Novavax Inc |
Vlps quiméricas de gripe aviária
|
|
US20090169615A1
(en)
*
|
2007-12-26 |
2009-07-02 |
Pinsky Mark A |
Collagen Formulations for Improved Skin Care
|
|
US8455514B2
(en)
*
|
2008-01-17 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-and 7-amino isoquinoline compounds and methods for making and using the same
|
|
US10251839B2
(en)
*
|
2008-01-22 |
2019-04-09 |
Igi Laboratories, Inc. |
Lipid vesicles derived from olive oil fatty acids
|
|
EP2285961A4
(de)
|
2008-05-15 |
2012-10-17 |
Topigen Pharmaceuticals Inc |
Oligonukleotide zur behandlung von entzündungen und neoplastischer zellvermehrung
|
|
CN102037119B
(zh)
|
2008-05-23 |
2015-06-24 |
Siwa有限公司 |
促进再生的方法、组合物及设备
|
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
|
EP2369923B1
(de)
*
|
2008-11-26 |
2016-06-22 |
Viroblock SA |
Verfahren zur hemmung von gram-positiv-bakterien unter verwendung von nicht-phospholipid-enthaltenden lipid-vesikeln
|
|
ES2987238T3
(es)
|
2008-12-09 |
2024-11-14 |
Novavax Inc |
Proteínas F del RSV modificadas y métodos de su uso
|
|
WO2010126626A2
(en)
|
2009-05-01 |
2010-11-04 |
Aerie Pharmaceuticals, Inc. |
Dual mechanism inhibitors for the treatment of disease
|
|
EP3871671A3
(de)
|
2009-07-29 |
2022-03-09 |
Olsen, Elise |
Fp rezeptorantagonisten zur hemmung von haarwachstum
|
|
US10143652B2
(en)
|
2009-09-23 |
2018-12-04 |
Curirx Inc. |
Methods for the preparation of liposomes
|
|
CA2781529C
(en)
|
2009-09-23 |
2017-10-24 |
Indu Javeri |
Methods for the preparation of liposomes comprising docetaxel
|
|
EP3366695B1
(de)
|
2009-12-17 |
2021-07-07 |
Children's Medical Center Corporation |
Aus saposin-a gewonnene peptide und verwendungen davon
|
|
WO2012047629A2
(en)
|
2010-09-27 |
2012-04-12 |
Siwa Corporation |
Selective removal of age-modified cells for treatment of ather0sclerosis
|
|
WO2012061815A2
(en)
|
2010-11-05 |
2012-05-10 |
Novavax Inc. |
RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPs)
|
|
US8721571B2
(en)
|
2010-11-22 |
2014-05-13 |
Siwa Corporation |
Selective removal of cells having accumulated agents
|
|
US20120310140A1
(en)
|
2010-12-01 |
2012-12-06 |
Spinal Modulation, Inc. |
Directed delivery of agents to neural anatomy
|
|
EP2720721B1
(de)
|
2011-06-17 |
2017-08-30 |
President and Fellows of Harvard College |
Frizzled 2 als zielmolekül für therapeutische antikörper bei der behandlung von krebs
|
|
CA2877102C
(en)
|
2011-06-29 |
2020-06-30 |
Avidas Pharmaceuticals Llc |
Topical formulations including lipid microcapsule delivery vehicles and their uses
|
|
WO2013066438A2
(en)
|
2011-07-22 |
2013-05-10 |
President And Fellows Of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
EP3560509B1
(de)
|
2011-12-22 |
2024-01-31 |
Children's Medical Center Corporation |
Aus saposin-a gewonnene peptide und verwendungen davon
|
|
US9737480B2
(en)
|
2012-02-06 |
2017-08-22 |
President And Fellows Of Harvard College |
ARRDC1-mediated microvesicles (ARMMs) and uses thereof
|
|
CA2866392C
(en)
|
2012-03-30 |
2023-10-24 |
Washington University |
Methods for modulating tau expression for reducing seizure and modifying a neurodegenerative syndrome
|
|
BR112015022156A2
(pt)
|
2013-03-14 |
2017-11-14 |
Isis Pharmaceuticals Inc |
composições e métodos para modular a expressão de tau
|
|
ES2776199T3
(es)
|
2013-03-15 |
2020-07-29 |
Aerie Pharmaceuticals Inc |
Conjugados de compuestos de isoquinolina y prostaglandinas
|
|
US10376562B2
(en)
|
2013-03-15 |
2019-08-13 |
The Jackson Laboratory |
Methods for promoting wound healing and hair growth comprising GDNF administration
|
|
US20140325490A1
(en)
*
|
2013-04-25 |
2014-10-30 |
Hewlett-Packard Development Company, L.P. |
Classifying Source Code Using an Expertise Model
|
|
TWI702046B
(zh)
|
2013-07-19 |
2020-08-21 |
美商Ionis製藥公司 |
用於調節τ蛋白表現之組合物
|
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
|
EP3046579A1
(de)
|
2013-09-19 |
2016-07-27 |
Novavax, Inc. |
Immunogene zusammensetzungen und verfahren gegen das mers-coronavirus
|
|
US20150166984A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting alpha-antitrypsin point mutations
|
|
RU2016122918A
(ru)
*
|
2013-12-23 |
2018-01-30 |
Дэрмопартнерс, С.Л. |
Способ получения липосом ретинальдегида или других предшественников ретиноевой кислоты и образующийся таким образом продукт
|
|
AU2015298571B2
(en)
|
2014-07-30 |
2020-09-03 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
CA2959629C
(en)
|
2014-09-03 |
2023-10-31 |
Boehringer Ingelheim International Gmbh |
Compound targeting il-23a and tnf-alpha and uses thereof
|
|
AU2015318036B2
(en)
|
2014-09-19 |
2021-07-01 |
Siwa Corporation |
Anti-AGE antibodies for treating inflammation and auto-immune disorders
|
|
US9816080B2
(en)
|
2014-10-31 |
2017-11-14 |
President And Fellows Of Harvard College |
Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
|
|
US9993535B2
(en)
|
2014-12-18 |
2018-06-12 |
Siwa Corporation |
Method and composition for treating sarcopenia
|
|
US10358502B2
(en)
|
2014-12-18 |
2019-07-23 |
Siwa Corporation |
Product and method for treating sarcopenia
|
|
US10487324B2
(en)
|
2015-02-25 |
2019-11-26 |
Washington University |
Methods to detect motor neuron disease comprising micro-RNAs
|
|
PE20180774A1
(es)
|
2015-07-23 |
2018-05-07 |
Boehringer Ingelheim Int |
Compuesto que se dirige a il-23a y al factor de activacion de linfocitos b (baff) y usos de estos
|
|
CN114617959A
(zh)
|
2015-09-03 |
2022-06-14 |
诺瓦瓦克斯股份有限公司 |
具有改进的稳定性和免疫原性的疫苗组合物
|
|
BR112018007422A2
(pt)
|
2015-10-13 |
2018-10-30 |
Siwa Corp |
anticorpos anti-age e métodos de uso dos mesmos
|
|
WO2017070632A2
(en)
|
2015-10-23 |
2017-04-27 |
President And Fellows Of Harvard College |
Nucleobase editors and uses thereof
|
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
|
WO2017086941A1
(en)
|
2015-11-17 |
2017-05-26 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
|
IL283726B2
(en)
|
2016-02-19 |
2025-05-01 |
Siwa Corp |
A preparation containing an antibody to advanced glycation end products (AGE) for use in the treatment of breast cancer
|
|
US10435682B2
(en)
|
2016-02-19 |
2019-10-08 |
University Of South Florida |
Arginine deiminase gene therapy for disordered proteins
|
|
EP3443007A1
(de)
|
2016-04-15 |
2019-02-20 |
Siwa Corporation |
Anti-age-antikörper zur behandlung von neurodegenerativen erkrankungen
|
|
SG11201810210UA
(en)
|
2016-06-08 |
2018-12-28 |
Childrens Medical Center |
Engineered botulinum neurotoxins
|
|
US11213585B2
(en)
|
2016-06-23 |
2022-01-04 |
Siwa Corporation |
Vaccines for use in treating various diseases and disorders
|
|
EP3481852B1
(de)
|
2016-07-08 |
2022-12-07 |
Children's Medical Center Corporation |
Neuartiges botulinumneurotoxin und dessen derivate
|
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
|
CN106268551B
(zh)
*
|
2016-08-09 |
2018-11-20 |
中国石油大学(华东) |
一种具有光捕获功能的多级复合微胶囊的制备方法
|
|
AU2017308889B2
(en)
|
2016-08-09 |
2023-11-09 |
President And Fellows Of Harvard College |
Programmable Cas9-recombinase fusion proteins and uses thereof
|
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
WO2018045091A1
(en)
|
2016-08-31 |
2018-03-08 |
Aerie Pharmaceuticals, Inc. |
Ophthalmic compositions
|
|
MD3519572T2
(ro)
|
2016-09-29 |
2024-03-31 |
Biogen Ma Inc |
Compuși și procedee de reducere a expresiei Tau
|
|
EP3518981A4
(de)
|
2016-10-03 |
2020-06-10 |
President and Fellows of Harvard College |
Abgabe von therapeutischen rnas über arrdc1-vermittelte mikrovesikel
|
|
KR20240007715A
(ko)
|
2016-10-14 |
2024-01-16 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 에디터의 aav 전달
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
KR102569848B1
(ko)
|
2016-12-23 |
2023-08-25 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
Pcsk9의 유전자 편집
|
|
US10925937B1
(en)
|
2017-01-06 |
2021-02-23 |
Siwa Corporation |
Vaccines for use in treating juvenile disorders associated with inflammation
|
|
US10961321B1
(en)
|
2017-01-06 |
2021-03-30 |
Siwa Corporation |
Methods and compositions for treating pain associated with inflammation
|
|
US10858449B1
(en)
|
2017-01-06 |
2020-12-08 |
Siwa Corporation |
Methods and compositions for treating osteoarthritis
|
|
US10995151B1
(en)
|
2017-01-06 |
2021-05-04 |
Siwa Corporation |
Methods and compositions for treating disease-related cachexia
|
|
WO2018165504A1
(en)
|
2017-03-09 |
2018-09-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
|
KR20190123328A
(ko)
|
2017-03-09 |
2019-10-31 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
암 백신
|
|
CN110914310A
(zh)
|
2017-03-10 |
2020-03-24 |
哈佛大学的校长及成员们 |
胞嘧啶至鸟嘌呤碱基编辑器
|
|
IL306092A
(en)
|
2017-03-23 |
2023-11-01 |
Harvard College |
Nucleic base editors that include nucleic acid programmable DNA binding proteins
|
|
CA3057872A1
(en)
|
2017-03-31 |
2018-10-04 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
|
BR112019021471A2
(pt)
|
2017-04-13 |
2020-05-12 |
Siwa Corporation |
Anticorpo monoclonal humanizado de produto final da glicação avançada
|
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
|
CN111148509A
(zh)
|
2017-07-24 |
2020-05-12 |
诺瓦瓦克斯股份有限公司 |
治疗呼吸系统疾病的方法和组合物
|
|
EP3658573A1
(de)
|
2017-07-28 |
2020-06-03 |
President and Fellows of Harvard College |
Verfahren und zusammensetzungen zur entwicklung von basiseditoren unter verwendung von phagenunterstützter kontinuierlicher entwicklung (pace)
|
|
EP3676376B1
(de)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
Hocheffiziente baseneditoren mit gam
|
|
CN112105379A
(zh)
|
2017-09-29 |
2020-12-18 |
儿童医学中心公司 |
神经毒素样毒素及其用途
|
|
CA3082251A1
(en)
|
2017-10-16 |
2019-04-25 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
|
US11541120B2
(en)
|
2017-12-05 |
2023-01-03 |
Anthos Partners, Lp |
Phosphonium-based ionic drug conjugates
|
|
US12406749B2
(en)
|
2017-12-15 |
2025-09-02 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
US11518801B1
(en)
|
2017-12-22 |
2022-12-06 |
Siwa Corporation |
Methods and compositions for treating diabetes and diabetic complications
|
|
US10538553B2
(en)
|
2018-01-05 |
2020-01-21 |
University Of South Florida |
Compounds for the treatment of neurodegenerative diseases
|
|
WO2019168953A1
(en)
|
2018-02-27 |
2019-09-06 |
President And Fellows Of Harvard College |
Evolved cas9 variants and uses thereof
|
|
US10507226B1
(en)
|
2018-05-02 |
2019-12-17 |
University Of South Florida |
N-amino peptide beta-sheet mimics for the treatment of Alzheimer's disease
|
|
KR102853088B1
(ko)
|
2018-05-11 |
2025-09-02 |
빔 테라퓨틱스, 인크. |
프로그래밍가능한 염기 편집기 시스템을 이용하여 단일염기다형성을 편집하는 방법
|
|
WO2019226953A1
(en)
|
2018-05-23 |
2019-11-28 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
EP3820495A4
(de)
|
2018-07-09 |
2022-07-20 |
The Broad Institute Inc. |
Rna-programmierbare epigenetische rna-modifikatoren und deren verwendungen
|
|
EP3826670A1
(de)
|
2018-07-23 |
2021-06-02 |
Siwa Corporation |
Verfahren und zusammensetzungen zur behandlung chronischer effekte von strahlung und chemischer exposition
|
|
KR102894715B1
(ko)
|
2018-08-03 |
2025-12-03 |
빔 테라퓨틱스, 인크. |
핵산 표적 서열을 변형시키기 위한 다중-이펙터 핵염기 편집기 및 이를 이용하는 방법
|
|
US20240173430A1
(en)
|
2018-09-05 |
2024-05-30 |
The Broad Institute, Inc. |
Base editing for treating hutchinson-gilford progeria syndrome
|
|
AU2019337703B2
(en)
|
2018-09-14 |
2023-02-02 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
WO2020102659A1
(en)
|
2018-11-15 |
2020-05-22 |
The Broad Institute, Inc. |
G-to-t base editors and uses thereof
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
WO2020181178A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through thymine alkylation
|
|
WO2020181193A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenosine methylation
|
|
WO2020181195A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenine excision
|
|
WO2020181180A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to c:g base editors and uses thereof
|
|
WO2020181202A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to t:a base editing through adenine deamination and oxidation
|
|
WO2020191241A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
WO2020210751A1
(en)
|
2019-04-12 |
2020-10-15 |
The Broad Institute, Inc. |
System for genome editing
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
WO2020236982A1
(en)
|
2019-05-20 |
2020-11-26 |
The Broad Institute, Inc. |
Aav delivery of nucleobase editors
|
|
US20220259617A1
(en)
|
2019-06-13 |
2022-08-18 |
The General Hospital Corporation |
Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
|
|
US20220315906A1
(en)
|
2019-08-08 |
2022-10-06 |
The Broad Institute, Inc. |
Base editors with diversified targeting scope
|
|
WO2021030666A1
(en)
|
2019-08-15 |
2021-02-18 |
The Broad Institute, Inc. |
Base editing by transglycosylation
|
|
CA3153563A1
(en)
|
2019-09-09 |
2021-03-18 |
Beam Therapeutics Inc. |
Novel crispr enzymes, methods, systems and uses thereof
|
|
EP4034088A4
(de)
|
2019-09-26 |
2023-10-11 |
President and Fellows of Harvard College |
Protein-1- (arrdc1)-konstrukte enthaltende minimale arrestin-domäne
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
WO2021108717A2
(en)
|
2019-11-26 |
2021-06-03 |
The Broad Institute, Inc |
Systems and methods for evaluating cas9-independent off-target editing of nucleic acids
|
|
CA3162908A1
(en)
|
2019-12-03 |
2021-06-10 |
Beam Therapeutics Inc. |
Synthetic guide rna, compositions, methods, and uses thereof
|
|
AU2021214064A1
(en)
|
2020-01-27 |
2022-08-18 |
Novavax, Inc. |
Coronavirus vaccine formulations
|
|
US10953089B1
(en)
|
2020-01-27 |
2021-03-23 |
Novavax, Inc. |
Coronavirus vaccine formulations
|
|
CA3166153A1
(en)
|
2020-01-28 |
2021-08-05 |
The Broad Institute, Inc. |
Base editors, compositions, and methods for modifying the mitochondrial genome
|
|
US20230235309A1
(en)
|
2020-02-05 |
2023-07-27 |
The Broad Institute, Inc. |
Adenine base editors and uses thereof
|
|
WO2021158999A1
(en)
|
2020-02-05 |
2021-08-12 |
The Broad Institute, Inc. |
Gene editing methods for treating spinal muscular atrophy
|
|
WO2021222318A1
(en)
|
2020-04-28 |
2021-11-04 |
The Broad Institute, Inc. |
Targeted base editing of the ush2a gene
|
|
US20230181730A1
(en)
|
2020-05-01 |
2023-06-15 |
Siwa Corporation |
Methods of treating infections
|
|
CA3177481A1
(en)
|
2020-05-08 |
2021-11-11 |
David R. Liu |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
|
BR112023001272A2
(pt)
|
2020-07-24 |
2023-04-04 |
Massachusetts Gen Hospital |
Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células
|
|
WO2022093195A1
(en)
|
2020-10-27 |
2022-05-05 |
Siwa Corporation |
Methods and compositions for treating osteoarthritis using anti-age antibodies or age antigens
|
|
WO2022094051A2
(en)
|
2020-10-28 |
2022-05-05 |
Children's Medical Center Corporation |
Truncated modified recombinant adamts13 and uses thereof
|
|
WO2022125776A2
(en)
|
2020-12-09 |
2022-06-16 |
Siwa Corporation |
Methods and compositions for treating kidney diseases
|
|
JP2024507533A
(ja)
|
2021-02-19 |
2024-02-20 |
ビーム・セラピューティクス・インコーポレイテッド |
遺伝子治療のための組み換え狂犬病ウイルス
|
|
KR20230158531A
(ko)
|
2021-03-23 |
2023-11-20 |
빔 테라퓨틱스, 인크. |
신규 crispr 효소, 방법, 시스템 및 그 용도
|
|
EP4323501A1
(de)
|
2021-04-16 |
2024-02-21 |
Beam Therapeutics Inc. |
Genetische modifikation von hepatozyten
|
|
JP2024516309A
(ja)
|
2021-05-05 |
2024-04-12 |
ノババックス,インコーポレイテッド |
コロナウイルス組成物及びインフルエンザ組成物ならびにそれらの使用方法
|
|
AU2022285744A1
(en)
|
2021-06-02 |
2023-12-14 |
Beam Therapeutics Inc. |
Circular guide rnas for crispr/cas editing systems
|
|
WO2022261509A1
(en)
|
2021-06-11 |
2022-12-15 |
The Broad Institute, Inc. |
Improved cytosine to guanine base editors
|
|
KR20240037299A
(ko)
|
2021-07-23 |
2024-03-21 |
빔 테라퓨틱스, 인크. |
Crispr/cas 편집 시스템용 가이드 rna
|
|
CA3229602A1
(en)
|
2021-08-20 |
2023-02-23 |
Siwa Corporation |
Methods and compositions for treating fibrotic diseases
|
|
CN118369429A
(zh)
|
2021-09-08 |
2024-07-19 |
比姆医疗股份有限公司 |
病毒引导rna递送
|
|
US20240417719A1
(en)
|
2021-10-25 |
2024-12-19 |
The Broad Institute, Inc. |
Methods and compositions for editing a genome with prime editing and a recombinase
|
|
IL312721A
(en)
|
2021-11-23 |
2024-07-01 |
Cellectis Sa |
Novel TALE protein scaffolds with improved on-target/off-target activity ratios
|
|
IL313146A
(en)
|
2021-12-03 |
2024-07-01 |
Harvard College |
Self-assembling virus-like particles for delivery of prime editors and methods of making and using same
|
|
AU2022400961A1
(en)
|
2021-12-03 |
2024-05-30 |
President And Fellows Of Harvard College |
Self-assembling virus-like particles for delivery of nucleic acid programmable fusion proteins and methods of making and using same
|
|
AU2022413670A1
(en)
|
2021-12-17 |
2024-07-04 |
Beam Therapeutics Inc. |
Crispr enzymes, methzods, systems and uses thereof
|
|
WO2023196802A1
(en)
|
2022-04-04 |
2023-10-12 |
The Broad Institute, Inc. |
Cas9 variants having non-canonical pam specificities and uses thereof
|
|
WO2023196772A1
(en)
|
2022-04-04 |
2023-10-12 |
Beam Therapeutics Inc. |
Novel rna base editing compositions, systems, methods and uses thereof
|
|
WO2023205687A1
(en)
|
2022-04-20 |
2023-10-26 |
The Broad Institute, Inc. |
Improved prime editing methods and compositions
|
|
CN120456933A
(zh)
|
2022-04-28 |
2025-08-08 |
布罗德研究所股份有限公司 |
编码碱基编辑器的aav载体及其用途
|
|
EP4532527A1
(de)
|
2022-05-27 |
2025-04-09 |
The Broad Institute, Inc. |
Verbesserte editoren für mitochondriale basen und verfahren zur bearbeitung mitochondrialer dna
|
|
WO2023240137A1
(en)
|
2022-06-08 |
2023-12-14 |
The Board Institute, Inc. |
Evolved cas14a1 variants, compositions, and methods of making and using same in genome editing
|
|
AU2023325079A1
(en)
|
2022-08-16 |
2025-02-13 |
President And Fellows Of Harvard College |
Evolved cytosine deaminases and methods of editing dna using same
|
|
EP4587560A1
(de)
|
2022-09-16 |
2025-07-23 |
Beam Therapeutics Inc. |
Grosse serinrekombinasen, systeme und verwendungen davon
|
|
WO2024077267A1
(en)
|
2022-10-07 |
2024-04-11 |
The Broad Institute, Inc. |
Prime editing methods and compositions for treating triplet repeat disorders
|
|
WO2024102157A1
(en)
|
2022-11-09 |
2024-05-16 |
Siwa Corporation |
Methods and compositions for treating diabetes and diabetic complications
|
|
WO2024138087A2
(en)
|
2022-12-23 |
2024-06-27 |
The Broad Institute, Inc. |
Methods and compositions for modulating cellular factors to increase prime editing efficiencies
|
|
WO2024155745A1
(en)
|
2023-01-18 |
2024-07-25 |
The Broad Institute, Inc. |
Base editing-mediated readthrough of premature termination codons (bert)
|
|
EP4652272A1
(de)
|
2023-01-18 |
2025-11-26 |
The Broad Institute Inc. |
Prime-editierungsvermitteltes durchlesen von codons mit vorzeitiger terminierung (pert)
|
|
EP4662306A2
(de)
|
2023-02-09 |
2025-12-17 |
The Broad Institute Inc. |
Evolved-rekombinasen zur bearbeitung eines genoms in kombination mit prime-bearbeitung
|
|
WO2024206125A1
(en)
|
2023-03-24 |
2024-10-03 |
The Broad Institute, Inc. |
Use of prime editing for treating sickle cell disease
|
|
KR20260028193A
(ko)
|
2023-05-23 |
2026-03-03 |
더 브로드 인스티튜트, 인코퍼레이티드 |
개선된 에디팅 효율을 갖는 진화 및 조작된 프라임 에디터
|
|
US20250085282A1
(en)
|
2023-09-11 |
2025-03-13 |
Novavax, Inc. |
Method for detecting anti-sars-cov-2 spike (s) immunoglobulins
|
|
WO2025064678A2
(en)
|
2023-09-20 |
2025-03-27 |
The Broad Institute, Inc. |
Prime editing-mediated readthrough of frameshift mutations (perf)
|
|
WO2025081042A1
(en)
|
2023-10-12 |
2025-04-17 |
Renagade Therapeutics Management Inc. |
Nickase-retron template-based precision editing system and methods of use
|
|
US20250144200A1
(en)
|
2023-11-06 |
2025-05-08 |
Novavax, Inc. |
Intranasal immunogenic compositions
|
|
AU2024381770A1
(en)
|
2023-11-15 |
2026-05-28 |
Slate Bio, Inc. |
Bifunctional il-2 and il-33 proteins for treating autoimmune disease
|
|
WO2025106685A1
(en)
|
2023-11-15 |
2025-05-22 |
Slate Bio, Inc. |
Interleukin-2 superkine and interleukin-33, compositions and uses thereof
|
|
WO2025106663A1
(en)
|
2023-11-15 |
2025-05-22 |
Slate Bio, Inc. |
Interleukin-33 variants, compositions and uses thereof
|
|
WO2025188687A1
(en)
|
2024-03-04 |
2025-09-12 |
Beam Therapeutics Inc. |
Stable rna compositions with stem loop, and methods thereof
|
|
WO2025259863A1
(en)
|
2024-06-12 |
2025-12-18 |
Orbital Therapeutics, Inc. |
Thermostable ribonuclease r for circular rna purification
|
|
WO2026024856A2
(en)
|
2024-07-23 |
2026-01-29 |
The Broad Institute, Inc. |
Compositions and methods for production of double-stranded dna in cells for programmable gene integration
|
|
WO2026046724A1
(en)
|
2024-08-30 |
2026-03-05 |
Cellectis Sa |
Tale protein scaffolds involving fusions of monopartite and bipartite nls
|
|
WO2026072421A2
(en)
|
2024-09-27 |
2026-04-02 |
The Broad Institute, Inc. |
Base editing methods and compositions for editing prnp in the treatment of prion disease
|
|
WO2026136461A1
(en)
|
2024-12-17 |
2026-06-25 |
The Broad Institute, Inc. |
Prime editing-mediated readthrough of premature termination codons (pert)
|